最新观点
Insights From Our Experts
Articles
Continuous Manufacturing of Pharmaceutical Products: The New Norm
The life sciences sector is changing for the new pharma generation with the introduction of many forms of updated technology and solutions. Continuous manufacturing (CM) is a perfect example. CM is a method for manufacturing pharmaceutical…
Unlocking Your Full North American Potential: Coordinating Launches in The U.S. and Canada
Posted by
Adam Hardy , Charles Pirraglia , Deborah Brown , Kerem Can Alp , Ryan H. Brown on 9 月 6, 20239/6/23
Discover the groundbreaking strategy that could redefine pharmaceutical launches and propel your product’s success across North America. In the realm of pharmaceutical launches, a paradigm shift is underway, challenging the conventional sequential approach and calling for…
Unlocking Global Success: The Crucial Role of Integrated HEOR Programs in New Product Launches
Posted on 8 月 25, 20238/25/23
Author: Kirk Szafranski, Director, HEOR, Value & Evidence Health Economics and Outcomes Research (HEOR) programs play a pivotal role in assessing a product’s value, cost-effectiveness, and real-world impact on patient outcomes, which are critical factors influencing…
The Art of Simplifying Pharmacovigilance – Part V: Deconstructing Automation
The use of automation continues to be on the rise, and that trajectory is not slowing down anytime soon, if ever. In relation to pharmacovigilance, automation’s ascent and how it is impacting the industry is especially…
The Rising Demand for Light Medical Aesthetic in China
“The Rising Demand for Light Medical Aesthetic in China” provides a captivating insight into the surging popularity of non-surgical medical aesthetics in China. The article highlights the rapid growth of the medical aesthetic market and the…
Revolutionizing Vaccines: The Rise of mRNA Technology in China
Key Contributors: Robin Arnold, Executive Vice President; Renyang Liu, Engagement Manager; Nicole Li, Analyst Discover how mRNA technology is transforming the field of vaccines in China. From the evolution of vaccine development to the rapid progress…
Maximizing Potential: Essential Steps for Successful Commercialization of Cell and Gene Therapies
Introduction Cell and gene therapy (CGT) products have significantly enhanced the quality of life for millions of patients impacted by medical conditions that are untreatable with traditional medicines or surgeries such as certain cancers, inherited and…
Maximizing Product Launch Success: The Importance of Conducting Comprehensive Business Simulation Exercises
Product launch preparedness is a vital aspect of bringing new products to market, particularly in the pharmaceutical industry where patients’ health and well-being can be impacted, in addition to the brand’s success and overall reputation. As…
The Art of Simplifying Pharmacovigilance – Part IV: Streamlining Vendor Engagement for Marketing Authorization Holders
It is often overlooked how many vendors a Marketing Authorization Holder (MAH) engages with. The more you spread your resources, the more scattered your focus becomes. Conversely, the more you concentrate your efforts, the more you…
The Art of Simplifying Pharmacovigilance – Part III: Unlocking Efficiency Through Consolidation
Just a few years ago, accessing entertainment on television was simple. However, the emergence of Over The Top applications for streaming content has made it complex, requiring users to manage multiple accounts and subscriptions. Consequently, users…